The use of collagenase in the treatment of Peyronie's disease
- PMID: 2991611
- DOI: 10.1016/s0022-5347(17)47123-0
The use of collagenase in the treatment of Peyronie's disease
Abstract
Purified clostridial collagenase was administered intralesionally in 31 men with Peyronie's disease. Within 4 weeks of treatment 20 patients showed an objective improvement. Pain was eliminated in 13 of 14 patients with this complaint at presentation within the same 4-week period. The ability to have intercourse was restored in 3 of 4 patients with this problem. Except for a small corporeal rupture at the site of injection in 1 patient, no significant untoward effects were noted. During the mean 9.8-month followup 1 recurrence of bending was noted.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources